Protective Effects of Zonisamide Against Rotenone-Induced Neurotoxicity

Salvatore Condello(Indiana University Health), Francesco Pisani(University of Messina), Riccardo Ientile(University of Messina), Daniela Caccamo(University of Messina), Giuseppa Visalli(University of Messina), Nadia Ferlazzo(University of Messina), Paolo Calabresi(Università Cattolica del Sacro Cuore), Gregorio Costa(University of Messina), Monica Currò(University of Messina), Laura Rosa Pisani(Regenxbio (United States)), Cinzia Costa(Diagnostics for the Real World (United States))
Neurochemical Research
October 19, 2013
10.1007/s11064-013-1181-2
Cited by 23

Related Papers

Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy
|Movement Disorders|2017|846
Alpha-synuclein in Parkinson’s disease and other synucleinopathies: from overt neurodegeneration back to early synaptic dysfunction
|Cell Death and Disease|2023|710
Valproic Acid and Epilepsy: From Molecular Mechanisms to Clinical Evidences
|Current Neuropharmacology|2018|368
Dopamine and cAMP-regulated phosphoprotein 32 kDa controls both striatal long-term depression and long-term potentiation, opposing forms of synaptic plasticity.
|PubMed|2000|347
Dopamine and cAMP-Regulated Phosphoprotein 32 kDa Controls Both Striatal Long-Term Depression and Long-Term Potentiation, Opposing Forms of Synaptic Plasticity
|Journal of Neuroscience|2000|331